RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the NASDAQ OMX 24th Investor Program (in association with Piper Jaffray) in London, UK on Wednesday, June 23 at 5:00 a.m. ET.
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the NASDAQ OMX 24th Investor Program (in association with Piper Jaffray) in London, UK on Wednesday, June 23 at 5:00 a.m. ET.
